Bodhtree Consulting Limited announced a significant leadership transition with the appointment of Mr. Sreenivasa Rao Ravinuthala as its new Chairman and an Additional Independent Director for a five-year term, effective February 27, 2026. Mr. Ravinuthala brings over three decades of experience, including his crucial role as the Resolution Professional during the company’s Corporate Insolvency Resolution…
Please note that by blocking any or all cookies you may not have access to certain features, content or personalization. For more information see our Cookie Policy. To enable cookies, follow the instructions for your browser below. Facebook App: Open links in External Browser There is a specific issue with the Facebook in-app browser intermittently…
Franklin Global Trust enters liquidation, scheme approved Investing.com Read the original article here
Aspen Reports No New Developments in Liquidation of Key Subsidiaries TipRanks Read the original article here
Autagco Deconsolidates Superfood Kitchen as Liquidation Advances TipRanks Read the original article here
The East India Company – once the most powerful commercial enterprise in the world – has shut down again. Its modern revival as a London luxury retailer, owned by Indian entrepreneur Sanjiv Mehta, has gone into liquidation. The company appointed liquidators in October 2025. Here’s a more detailed insight. A British trading corporation founded in…
Alpha DX Group Reports No New Developments in Ongoing Liquidation TipRanks Read the original article here
Supplied ContentAuckland, February 27, 2026 In a significant development, Iconic Food 4 Less New Lynn Ltd has entered into liquidation. The High Court in Auckland made this decision on February 24, 2026, following a petition from a creditor, supported by other major creditors. Pritesh Patel, a Licensed Insolvency Practitioner, is the Court-Appointed Liquidator. The Liquidator…
Viracta, Therapeutics 27.02.2026 – 09:54:22 | boerse-global.de Viracta Therapeutics enters liquidation, focusing on monetizing its Nana-val oncology drug candidate and IP portfolio amid a tough biotech funding climate. The biopharmaceutical firm Viracta Therapeutics is now in the midst of a formal operational wind-down. This…
Please note that by blocking any or all cookies you may not have access to certain features, content or personalization. For more information see our Cookie Policy. To enable cookies, follow the instructions for your browser below. Facebook App: Open links in External Browser There is a specific issue with the Facebook in-app browser intermittently…